Markstein R, Emson P
Preclinical Research, Sandoz Ltd., Basle, Switzerland.
Eur J Pharmacol. 1988 Jul 26;152(1-2):147-52. doi: 10.1016/0014-2999(88)90846-1.
At low concentrations, neurotensin (10(-9) M) enhanced electrically evoked release of dopamine. At higher concentrations, neurotensin (10(-7) M) also enhanced basal release of dopamine. The carboxy-terminal sequence of neurotensin-(8-13) was fully active and enhanced both electrically evoked and basal release. In contrast, the amino-terminal fragment neurotensin-(1-6) did not enhance electrically evoked release of dopamine even at high concentrations (10(-6) M). However, it retained the ability to enhance basal dopamine release. Combination of different doses of apomorphine with a subthreshold (10(-10) M) and submaximal concentrations (10(-9) M) of neurotensin gave clear additive effects. It is concluded that in the cat striatum neurotensin stimulates dopamine release by a direct effect on its own neurotensin receptor, and does not modulate the sensitivity of presynaptic dopamine autoreceptors. Furthermore, it is suggested that there exist at least two types of neurotensin receptors in the cat striatum. One type stimulates evoked dopamine release and another influences basal release of dopamine.
在低浓度时,神经降压素(10⁻⁹ M)增强电诱发的多巴胺释放。在较高浓度时,神经降压素(10⁻⁷ M)也增强多巴胺的基础释放。神经降压素 -(8 - 13)的羧基末端序列具有完全活性,可增强电诱发释放和基础释放。相比之下,氨基末端片段神经降压素 -(1 - 6)即使在高浓度(10⁻⁶ M)下也不增强电诱发的多巴胺释放。然而,它保留了增强多巴胺基础释放的能力。不同剂量的阿扑吗啡与阈下(10⁻¹⁰ M)和次最大浓度(10⁻⁹ M)的神经降压素联合使用产生明显的相加效应。得出的结论是,在猫纹状体中,神经降压素通过直接作用于其自身的神经降压素受体刺激多巴胺释放,而不调节突触前多巴胺自身受体的敏感性。此外,提示猫纹状体中至少存在两种类型的神经降压素受体。一种类型刺激诱发的多巴胺释放,另一种影响多巴胺的基础释放。